Skip to Content
Merck
CN
  • [Copper intoxication decreases lifespan and induces neurologic alterations in Drosophila melanogaster].

[Copper intoxication decreases lifespan and induces neurologic alterations in Drosophila melanogaster].

Investigacion clinica (2013-06-21)
José Luis Arcaya, Carlos Mario Tejeda, Ubalguis Salazar, Ernesto José Silva, Karla Urdaneta, Krystal Varela
ABSTRACT

Wilson disease is a hereditary disorder caused by mutations of the ATP7B gene, which leads to intoxication with copper as a result of an unbalance of copper homeostasis. The clinical manifestations resulting from this intoxication are related to the affectation of liver and the encephalon in most cases. Several animal models are currently available for the study of the malady. However, in such models no neurological symptoms are observed, which limits their use for the study of pathogenic effects of this disease on the central nervous system. The aim of the present study was to evaluate if copper feeding could induce a disease state in Drosophila melanogaster to model Wilson disease. The effect of the feeding of copper at the doses of 31 microM and 47 microM on the survival was initially evaluated. Next, behavioral experiments were conducted to determine whether the motor performance was altered by the 47 microM concentration. The results suggest that copper treatment decreases the viability of the flies. In addition, the decrease of viability was associated to an increase and decrease of spontaneous motor activity at early and late stages of the intoxication, respectively. Finally, the role of the dopaminergic neurotransmission system on the observed motor alterations was evaluated. The dopamine precursor L-dopa increased motor activity. In contrast, D2 receptor antagonist, Fluphenazine, was able to block both the increase and decrease of motor activity scores induced by copper. These results suggest that Drosophila melanogaster could be used as a model organism for the study of possible interventions with potential neuroprotective effects in Wilson disease.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Copper(II) sulfate, anhydrous, powder, ≥99.99% trace metals basis
Sigma-Aldrich
Copper(II) sulfate, ReagentPlus®, ≥99%
Sigma-Aldrich
Copper(II) sulfate solution, 4 % (w/v) (prepared from copper (II) sulfate pentahydrate)
Sigma-Aldrich
Copper(II) sulfate, puriss., meets analytical specification of Ph. Eur., BP, USP, anhydrous, 99-100.5% (based on anhydrous substance)
Sigma-Aldrich
Copper(II) sulfate, puriss. p.a., anhydrous, ≥99.0% (RT)
Supelco
Fluphenazine dihydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®